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IL-23 plays an important role in the development of arthritis and the IL-23 receptor
(IL-23R) is expressed on different types of T cells. However, it is not fully clear which
IL-23R+ T cells are critical in driving T cell-mediated synovitis. We demonstrate, using
knock-in IL-23R-GFP reporter (IL-23RGFP/+) mice, that CD4+CCR6+ T cells and γδ T cells, but
not CD8+ T cells, express the IL-23R(GFP). During early arthritis, IL-23R(GFP)+CD4+CCR6+
T cells, but not IL-23R(GFP)+ γδ T cells, were present in the inflamed joints.
IL-23RGFP/+ mice were bred as homozygotes to obtain IL-23RGFP/GFP (IL-23R deficient/
IL-23R−/−) mice, which express GFP under the IL-23R promotor. Arthritis progression and
joint damage were significantly milder in IL-23R−/− mice, which revealed less IL-17A+
cells in their lymphoid tissues. Surprisingly, IL-23R−/− mice had increased numbers of
IL-23R(GFP)+CD4+CCR6+ and CCR7+CD4+CCR6+ T cells in their spleen compared to WT,
and IL-23 suppressed CCR7 expression in vitro. However, IL-23R(GFP)+CD4+CCR6+ T cells
were present in the synovium of IL-23R−/− mice at day 4. Finally, adoptive transfer exper-
iments revealed that CD4+CCR6+ T cells and not γδ T cells drive arthritis progression.
These data suggest that IL-23R-dependent T cell-mediated synovitis is dependent on
CD4+CCR6+ T cells and not on γδ T cells.
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Introduction
The IL-23 signaling pathway has been implicated in different
autoimmune diseases including rheumatoid arthritis, multiple
sclerosis, inflammatory bowel disease, and psoriasis [1, 2]. IL-23
is mainly produced by myeloid cells such as dendritic cells (DCs)
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and macrophages [3], and belongs to the IL-12 cytokine family.
Similarly to the other family members, both the cytokine and
its receptor act as heterodimers. In this context, functional IL-23
consists of a complex formed by IL-23p19, which binds the IL-23R
subunit, and IL-12p40, which binds the IL-12Rβ1 subunit of the
IL-23 receptor [4–6]. IL-23R signals through the STAT3 pathway
resulting in pro-inflammatory cytokine production including
IL-17A, IL-22, IFNγ, GM-CSF, the expression of the chemokine
receptor CCR6 and the transcription factor RORγt [7]. While
RORγt is crucial for driving the differentiation of IL-17-producing
T cells [8], regulation of CCR6 expression is important for their
migration towards the site of inflammation [9, 10].
The IL-23R is expressed mainly on γδ T cells and on a small
fraction of CD4+ T cells, DCs and macrophages in the LNs of mice
during steady state [11]. However, the dynamics of IL-23R+ T cells
is different during inflammatory conditions. During experimental
autoimmune encephalomyelitis (EAE), IL-23R+ CD4+ T cells were
increased compared to na¨ıve condition and accumulated in the
inflamed CNS of mice [11]. Similarly, IL-23R+ γδ T17 cells accu-
mulated in the skin-draining LNs of mice during Aldara-induced
skin inflammation [12]. However, the kinetics of different IL-23R+
T cells during arthritic versus steady state conditions is not fully
investigated.
Previously, it was shown that mice deficient in IL-23p19 were
resistant to collagen-induced arthritis [13, 14]. We demonstrated
that the progression of antigen-induced arthritis (AIA) is depen-
dent on IL-23 and IL-17RA signaling, since both IL-23p19−/− and
IL-17RA−/− mice had significantly milder arthritis compared to
wild type (WT) [15]. While, in the joints of arthritic mice, both
IL-17A producing CD4+ T cells and γδ T cells were detected, there
was a significant decrease in these cells in the absence of IL-23.
This suggests that both cell types play a role in IL-23-mediated joint
inflammation. It should be noted that discrepancy exists between
IL-17A KO and IL-17RA−/− mice regarding the severity of AIA,
since IL-17A KO mice showed no difference in AIA severity [16],
suggesting that other IL-17 family members are involved.
Nevertheless, although the role of Th17 cells in IL-23-
dependent arthritis has been extensively studied and well-
appreciated [14, 17, 18], the relative significance of IL-23R+ γδ
T cells remains elusive [17, 19–23].
In the present study, we identified different types of IL-23R+
T cells in the joint draining LNs and the joints during the course
of AIA, using IL-23R-GFP reporter mice. Furthermore, we induced
AIA in WT and IL-23R−/− mice and analyzed T cells in their joints
and spleens during the peak of disease. Lastly, we investigated
which type of T cells are crucial for driving IL-23R-dependent
joint inflammation.
Results
IL-23R(GFP)+CD4+ T cells, but not γδ T cells, are
present in the joints during early arthritis
We aimed to identify IL-23R expressing cells using IL-23R reporter
(IL-23RGFP/+) mice in which the intracellular domain of the IL-23R
is replaced by GFP [11]. Since IL-23RGFP/+ mice have only one
functional il23r allele, we first assessed the severity of arthritis
in these mice by macroscopically assessing joint inflammation at
day 1, 4 or 7 after the induction of arthritis. Interestingly, both
the onset and the progression of arthritis in IL-23RGFP/+ mice
were similar to WT controls (Fig. 1A). Furthermore, the lymphoid
cells of both groups were equally capable of producing the pro-
inflammatory cytokines IL-17A and IL-17F (Fig. 1B and Supporting
Information Fig. 1).
Since the synovial inflammation in the AIA model is dependent
on T cells, we aimed to identify different types of IL-23R+ T cells in
this model. Therefore, we analyzed IL-23R(GFP) expression in the
T cells of the popliteal LNs (pLNs) of mice, which drain from the
joints (Fig. 2A and Supporting Information Fig. 2). IL-23R(GFP)
expression was found in γδ T cells and CD4+ T cells during both
na¨ıve and arthritic conditions, but not in CD8+ T cells (Fig. 2B).
Activated T cells downregulate the expression of the adhesion
molecule CD62L [24]. Notably, IL-23R(GFP) expression within
the CD4+CD62L− (effector/effector memory) T cell population
was confined to only CCR6+ cells, referred to as CD4+CCR6+
T cells in this paper.
Next, we assessed IL-23R(GFP) expression in the T cells of the
pLNs and the joints during the different phases of arthritis. In the
pLNs of na¨ıve mice, approximately 12% of γδ T cells expressed
the IL-23R(GFP) (Fig. 2C). The fraction of these cells increased
slightly at days 1 and 4, but decreased significantly at day 7.
In contrast to the pLNs, IL-23R(GFP)+ γδ T cells could not be
detected in the joints at day 1 of AIA (Fig. 2E). However, a small
proportion of γδ T cells was IL-23R(GFP)+ at day 4 of AIA and
increased significantly by day 7.
In na¨ıve pLNs, around 1% of CD4+CCR6+ T cells expressed
the IL-23R(GFP) (Fig. 2D). However, the fraction of these cells
increased significantly already at day 1 of arthritis, but decreased
gradually during the peak of disease in the pLNs. Also, in the spleen
and inguinal LNs, which drain from the site of immunization, the
percentage of IL-23R(GFP) expressing CD4+CCR6+ T cells was
increased during arthritis compared to na¨ıve condition (data not
shown). In contrast to γδ T cells, IL-23R(GFP)+CD4+CCR6+ T cells
could be detected in the joints of mice at day 1 of AIA (Fig. 2F), but
their fraction slightly decreased during days 4 and 7. These data
demonstrate that the kinetics of IL-23R(GFP)+ γδ T cells differ
from that of CD4+CCR6+ T cells in the pLNs and the joints during
the course of arthritis. Furthermore, IL-23R(GFP)+CD4+CCR6+
T cells are present at the site of inflammation during the early
phases of arthritis.
The progression of full-blown inflammatory arthritis
is dependent on IL-23R signaling
When IL-23RGFP/+ mice are bred as homozygotes, IL-23RGFP/GFP
mice can be obtained which are deficient for IL-23R signaling
(IL-23R−/− mice). To study the role of IL-23R signaling in a T cell-
mediated inflammatory arthritis, we induced AIA in IL-23R−/−
and WT mice, and monitored joint inflammation via macroscopic
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Figure 1. IL-23R-GFP reporter and WT
mice have similar susceptibility to AIA.
AIA was induced in IL-23RGFP/+ and WT
mice, and mice were sacrificed at days
1, 4, or 7 after arthritis induction. (A)
Macroscopic scores of joint inflammation.
Pooled data of two independent experi-
ments are depicted for day 1 (n = 5 mice
per group), day 4, and day 7 (n = 8 mice
per group). (B) IL-17A production assessed
by flow cytometry in the spleen at day 4
of AIA after stimulation of cells for 4 h
with PMA/ionomycin. MFI = mean fluo-
rescent intensity. Representative data of
two independent experiments given for
n = 4 mice per group per experiment.
Data are depicted as mean with SEM and
compared using Mann–Whitney test. p-
values <0.05 were considered statistically
significant.
scoring at days 1, 4, 7 and 10 after arthritis induction. Although
the onset of AIA was similar in both groups, the progression of
joint inflammation was significantly lower in IL-23R deficient mice
(Fig. 3A). In line with the macroscopic scores, histological analysis
of the knee joints revealed significantly less joint inflammation and
bone damage in IL-23R−/− mice at day 10 (Fig. 3B).
Since IL-23R−/− joints were less inflamed compared to WT,
we investigated if there were differences in T cell infiltration.
Therefore, we analyzed T cells in the joints by flow cytometry
at day 4 of AIA. Interestingly, total CD4+ T cell numbers were
significantly reduced in IL-23R−/− joints (Fig. 3C). Furthermore,
γδ T cell counts were lower compared to WT, although this was
not statistically significant. In contrast, CD8+ T cell numbers were
comparable between both groups, and total CD8+ T cell numbers
were low compared to CD4+ T cells and γδ T cells. Altogether,
these data indicate that IL-23R signaling is crucial for the progres-
sive phase, but not for the onset of AIA and suggest that T cell
infiltration in the inflamed joints plays an important role during
the progression of arthritis.
IL-23R(GFP)+CD4+CCR6+ T cells are increased
in the lymphoid tissues of IL-23R deficient mice
The previous data suggested that CD4+ T cell infiltration in
the joints is abrogated in the absence of IL-23R signaling. To
investigate if this is caused by any alterations in T cells in the lym-
phoid tissues, we analyzed both IL-23R(GFP)+ and IL-23R(GFP)−
T cells in the spleens of the mice at day 4 of AIA. Total cell
numbers of IL-23R(GFP) expressing γδ T cells were slightly lower
in the spleens of IL-23R−/− mice compared to IL-23RGFP/+ mice
(Fig. 4A). In contrast, IL-23R(GFP)+CD4+CCR6+ T cells were
significantly higher in the spleens (Fig. 4B) and inguinal LNs
(Supporting Information Fig. 3) of IL-23R−/− mice compared
to IL-23RGFP/+. Total cell count of IL-23R(GFP)− γδ T cells and
IL-23R(GFP)−CD4+CCR6+ T cells were similar between both
groups (Fig. 4A and B and Supporting Information Fig. 3). Despite
the increase in IL-23R(GFP)+CD4+CCR6+ T cells, splenic cells of
IL-23R−/− mice were less capable of producing IL-17A and IL-17F
(Fig. 4C and Supporting Information Fig. 4). These findings
suggest that IL-23R(GFP)+CD4+CCR6+ T cells have decreased
inflammatory potential and accumulate in the lymphoid tissues
of IL-23R−/− mice during arthritis.
A potential explanation for the accumulation of the
IL-23R(GFP)+CD4+CCR6+ T cells in the lymphoid tissues of
IL-23R deficient mice could be abnormalities in their migratory
capacity. Effector T cells migrate from lymphoid tissues towards
the site of inflammation under the influence of chemokines and
chemokine receptors. To investigate if chemokine receptor expres-
sion is altered in the absence of IL-23R signaling, we analyzed
CCR6 and CCR7 expression in the spleens of the mice at day 4
of AIA. The expression of CCR6, which is associated with T cell
migration towards the joints [9], was not different between
IL-23R(GFP)+CD4+CCR6+ T cells in both groups (Supporting
Information Fig. 5A). Thus, this does not explain the increase
in the number of these cells in the spleens.
Next, we focused on CCR7, which is downregulated on
activated T cells during their egress from lymphoid tissues
towards the site of inflammation [25]. Analysis of CCR7 gene
expression revealed almost six fold higher expression in IL-23R−/−
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Figure 2. IL-23R(GFP)+CD4+ T cells are present in the pLNs and joints during the early stages of arthritis. AIA was induced in IL-23RGFP/+ and WT
mice. Naı¨ve and arthritic mice were sacrificed at days 1, 4, or 7 of AIA. IL-23R(GFP) expression was assessed by flow cytometry. WTmice were used
as negative control for GFP signal. (A) Representative gating strategy for the analysis of T cells. Cells were pre-gated as indicated in Supporting
Information Fig. 2. (B) Representative plot of IL-23R(GFP)expression at day 1 of AIA in the LNs. CCR6+ cells were pre-gated for CD4 as depicted in
(A). (C-D) Quantification of (B) for IL-23R(GFP)+ (C) γδ T cells or (D) CD4+CCR6+ T cells in the pLNs of IL-23RGFP/+ mice. (E-F) IL-23R(GFP)+ (E) γδ T cells
or (F) CD4+ T cells in the joints of IL-23RGFP/+ mice. (E-F) Cells were pre-gated on CD45 and CD3. Pooled data of two independent experiments for
naı¨ve mice (n = 7 mice per group), AIA day 1 (n = 5 mice per group), and three independent experiments for AIA day 4 (n = 10 mice per group) and
day 7 (n = 12 mice per group) are depicted as mean with SEM. *p < 0.05, **p < 0.01, ***p < 0.001 (Kruskall–Wallis test).
splenocytes compared to WT (Fig. 5A). In order to further confirm
this, we analyzed CCR7 protein levels by flow cytometry. Total
number of CCR7 expressing γδ T cells was similar betweenWT and
IL-23R deficient mice (Fig. 5B). In contrast, CCR7+CD4+CCR6+
T cells were significantly higher in IL-23R−/− spleens (Fig. 5C).
However, CCR7 MFI on CD4+CCR6+ T cells was not significantly
different between both groups (Supporting Information Fig.
5B). To confirm that IL-23 has a role in the regulation of CCR7
expression, we stimulated splenocytes of WT mice for 3 days with
IL-23. CCR7 expression was reduced in the splenocytes of all mice
upon treatment with IL-23 (Fig. 5D).
Overall, these data suggest that IL-23R signaling plays a role
in the regulation of CCR7 expression on CD4+CCR6+ T cells.
IL-23R(GFP)+ γδ T cells and CD4+CCR6+ T cells
are present in the joints of arthritic IL-23R−/− mice
The previous data suggested that IL-23R(GFP)+CD4+CCR6+
T cells accumulated in the lymphoid tissues of IL-23R deficient
mice at the peak of disease (Fig. 4 and 5). Therefore we set out to
analyze these cells in the joints of mice at this time point. Inter-
estingly, both IL-23R(GFP) expressing γδ T cells and CD4+CCR6+
T cells were present in the joints of IL-23R deficient mice and
were even slightly higher than in IL-23RGFP/+ joints (Fig 6A and
B). These data suggest that IL-23R+ T cells are able to enter the
site of inflammation even in the absence of IL-23R signaling.
CD4+CCR6+ T cells, but not γδ T cells, are important
for IL-23R-dependent progression of arthritis
Since we detected both IL-23R(GFP)+ γδ T cells and
IL-23R(GFP)+CD4+CCR6+ T cells in the inflamed joints of mice
(Fig. 2E and F), we aimed to investigate which of these cells
are important for the progression of IL-23R-dependent arthritis.
Therefore, we adoptively transferred γδ T cells or CD4+CCR6+
T cells from immunized WT mice into IL-23R deficient mice and
induced AIA in the recipient mice. At day 4 of AIA, the knee
joints of the mice were assessed for joint inflammation. Inter-
estingly, while γδ T cells did not affect the disease severity,
WT CD4+CCR6+ T cells were able to induce arthritis in IL-23R
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Figure 3. IL-23R signaling is important during the progressive phase of arthritis. AIA was induced in WT and IL-23R−/− mice, and mice were
sacrificed at days 1, 4, 7, or 10 after arthritis induction. (A) Macroscopic scores of joint inflammation. (B) Representative hematoxylin and eosin
(H&E) staining and histologic scores of the knee joints at day 10 of AIA. Arrows indicate bone damage, scale 1:300. (C) Total CD4+, TCRγδ+, and
CD8+ T cell counts in the joints of mice at day 4 of AIA assessed by flow cytometry. Cells were pre-gated on CD45 and CD3. Pooled data of two
independent experiments with n = 5 mice per group for AIA day 1 and day 10, and three independent experiments for AIA day 4 (n = 10 mice per
group) and day 7 (n = 12 mice per group) are depicted as mean with SEM for per group. **p < 0.01, ***p < 0.001 (Mann–Whitney test).
deficient mice (Fig. 7). These data suggest that although both
CD4+CCR6+ T cells and γδ T cells express the IL-23R and are
present at the site of inflammation during the peak of disease,
specifically the CD4+CCR6+ T cells are important for IL-23R-
mediated joint inflammation.
Discussion
In this study, we demonstrate that IL-23R deficient mice are pro-
tected from the progression of AIA and have less bone damage.
In this context, CD4+CCR6+ T cells, but not γδ T cells, are crucial
for the progressive phase of arthritis. IL-23R is expressed on γδ
T cells and CD4+CCR6+ T cells, but not on CD8+ T cells, dur-
ing both na¨ıve and arthritic conditions. During the early phases
of arthritis, IL-23R+CD4+CCR6+ T cells were increased in the
pLNs of mice and were present in the joints, while IL-23R+ γδ
T cells were not present in the joints at this time point. Although
IL-23R+CD4+CCR6+ T cells and CCR7+CD4+CCR6+ T cells were
expanded in the lymphoid tissues of IL-23R deficient mice,
IL-23R+CD4+CCR6+ T cells were still present in the joints of these
mice.
IL-23RGFP/+ mice were used for studying the dynamics of
IL-23R+ T cells during arthritis. Despite having only one func-
tional IL-23R allele, these mice had similar susceptibility to arthri-
tis as their WT littermates. This is in line with an earlier study in
IL-23RGFP/+ mice, which reported responsiveness of both αβ T cells
and γδ T cells to IL-23 stimulation [26]. Furthermore, IL-23RGFP/+
mice had similar susceptibility to EAE as WT mice [11].
In contrast to IL-23RGFP/+ mice, IL-23RGFP/GFP (IL-23R−/−)
mice lack both alleles of the il23r and had significantly less severe
joint inflammation and damage. This is in line with previous stud-
ies in IL-23p19−/− mice [15, 27] and indicates that IL-23/IL-23R
signaling is crucial for the progressive phase of AIA. Importantly,
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Figure 4. Total IL-23R(GFP)+CD4+CCR6+ T cell numbers are higher in IL-23R deficient mice compared to WT. AIA was induced in WT, IL-23RGFP/+,
and IL-23R−/− mice and the spleens were harvested at day 4 after arthritis induction. Total IL-23R+ T cell count was determined using GFP
expression by flow cytometry. WTmice were used as negative control for GFP. (A) Total IL-23R(GFP)+ and IL-23R(GFP)− γδ T cell and (B) CD4+CCR6+
T cell numbers. Pooled data of three independent experiments are depicted for n = 10–12 mice per group. (C) % IL-17A+ cells and IL-17A MFI in
all cells assessed by flow cytometry in the spleen at day 4 of AIA. MFI = mean fluorescent intensity. Representative data of two independent
experiments given for n = 4 mice per group per experiment. Data are depicted as mean with SEM. **p < 0.01, ***p < 0.001 (Mann–Whitney test).
both IL-23p19−/− and IL-23R−/− mice are also knocked-out for
IL-39 (IL-23p19+ Ebi3 heterodimer) pathway [28]. Considering
the role of this pathway in systemic lupus erythematosus, it is plau-
sible that this pathway could also be involved in the AIA model.
Further studies should reveal if this pathway plays a role in AIA
and if IL-39R is expressed on CD4+CCR6+ T cells.
During the progressive phase of arthritis, the main infiltrat-
ing T cells that were found in the joints of WT mice were CD4+
and γδ T cells, while considerably lower numbers of CD8+ T cells
were detected. This suggests that the role of CD8+ T cells is lim-
ited in this model. Accordingly, a recent study demonstrated that
depletion of CD8+ T cells in mice did not affect chronic joint
inflammation and destruction in the newly generated mouse
model antigen- and collagen-induced arthritis [29]. Furthermore,
IL-23R was not expressed on CD8+ T cells during both na¨ıve
and arthritic conditions and CD8+ T cell infiltration in the joints
was independent of IL-23R signaling, which further supports the
notion that these cells are dispensable for the IL-23R-mediated
progressive phase of AIA.
Specifically IL-23R(GFP)+CD4+CCR6+ T cells were signifi-
cantly increased in the spleen and LNs of IL-23R−/− mice. One
possible explanation could be that these cells accumulate here
and could not egress from these tissues to migrate towards the
site of inflammation. However, IL-23R(GFP)+CD4+CCR6+ T cells
were still present in the joints of IL-23R−/− mice and were even
slightly higher compared to IL-23RGFP/+ mice. Another possible
explanation is that IL-23R deficient mice have increased thymic
output of IL-23R+CD4+CCR6+ T cells. Supporting this, IL-23 or
RORγt deficiency in mice resulted in defective apoptosis and neg-
ative selection of thymocytes during infection [30]. It remains to
be determined if the increase in IL-23R+CD4+CCR6+ T cells, due
to absence of IL-23R signaling, is caused by possible changes in
the thymic output of these cells.
Although the expression of CCR7 in CD4+CCR6+ T cells of
IL-23R−/− spleens was similar to WT, their total cell numbers
were significantly higher. In addition, treatment of splenocytes
with IL-23 decreased CCR7 gene expression, suggesting a role for
IL-23 in the regulation of CCR7 in CD4+CCR6+ T cells. It should be
noted that we have used whole spleens to investigate the effect of
IL-23 stimulation on CCR7 gene expression and that in addition to
CD4+ T cells, CCR7 is expressed on other immune cells including
CD8+ T cells and DCs [31, 32]. Since our data demonstrated
that CCR7+CD4+CCR6+ T cells, but not CCR7+ γδ T cells, were
increased in the spleens of IL-23R−/− mice, it is plausible that
IL-23 regulation of CCR7 expression is cell-extrinsic, involving
other immune cells. Further studies are required to investigate
if IL-23R deficiency specifically leads to an increase in number
of CCR7+CD4+CCR6+ T cells alone or (in)directly affects other
immune cells as well and what the potential effects are for the
function of these cells.
Interestingly, our finding that in contrast to
CCR7+CD4+CCR6+ T cells, CCR7+ γδ T cells were not increased
in the spleens of IL-23R−/− mice is supported by the study of
Vrieling et al. They demonstrated that γδ T cell homing to skin and
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Figure 5. CCR7+CD4+CCR6+ T cells are increased in the spleens of arthritic IL-23R−/− mice. AIA was induced in WT and IL-23R−/− mice and the
spleens were harvested at day 4 after arthritis induction. (A) CCR7 gene expression in the splenocytes was assessed by RT-PCR. (B) Total cell
numbers of CCR7+ γδ T cell or (C) CD4+CCR6+ T cells were assessed by flow cytometry. Cells were pre-gated as depicted as shown in Fig. 2A. (A–C)
Pooled data of two independent experiments with n = 7–10 mice per group. (D) Splenic cells of WT mice were cultured for 3 days with or without
IL-23 and CCR7 gene expression was assessed by RT-PCR. Data with n = 4 mice per group. Data are depicted as mean with SEM. *p < 0.05, **p < 0.01
(Mann–Whitney test).
migration to skin-draining LNs is not dependent on CCR7 [33].
This suggests that CCR7 expression is differently regulated in
CD4+ T cells versus γδ T cells and may have different roles on
these cells.
Our study demonstrated that γδ T cells were not important for
the progression of arthritis, however their contribution to the gen-
eration of pathogenic CD4+CCR6+ T cells during arthritis cannot
be excluded. Indeed, Petermann et al. demonstrated an important
role for IL-23R+ γδ T cells in maintaining Th17 cell pathogenic-
ity by antagonizing Treg cell-mediated suppression of αβ T cells,
and the conversion of conventional Th cells into Treg cells [26].
Likewise, in experimental autoimmune uveoretinitis, activated γδ
T cells could induce IL-23 production by DCs in vitro and increased
the generation of IL-17A producing αβ T cells [34]. These studies
suggest a role for γδ T cells in modulation of CD4+CCR6+ T cell
pathogenicity.
We used the entire CD4+CCR6+ T cell population rather than
the IL-23R+ fraction for the adoptive transfer into IL-23R deficient
mice. This was due to technical reasons; since the fraction of IL-
23R+ cells within the CD4+CCR6+ T cell population is relatively
small, it was challenging to obtain enough cells for the transfer.
However, this raises the question whether all CD4+CCR6+ T cells
are important for joint inflammation or that the IL-23R+ fraction
of CD4+CCR6+ T cells is sufficient. Previously, Ghoreschi et al.
demonstrated that adoptively transferred Th17 cells that were
generated with IL-23, induced more severe EAE in RAG−/− recip-
ient mice than Th17 cells that were induced with TGF-β [35]. In
addition, Komatsu et al. demonstrated the pathogenic conversion
of FOXP3+ T cells into IL-23R expressing Th17 cells that promoted
arthritis [36]. These studies indicate that IL-23R expression on
CD4+ T cells is associated with the pathogenicity of these cells.
The transfer experiments in our study have some technical limi-
tations. Sincewe have used αCD3 beads for sorting T cells, thismay
have resulted in activation and increased cytokine production by
T cells. Therefore, this does not completely determine the IL-23R
signaling dependency of CD4+CCR6+ T cells in mediating inflam-
mation in our model. However, the data of the adoptive transfer
experiments are in line with Figs. 2E and F, which demonstrate
that CD4+IL-23R(GFP)+ cells were present in the joints already
one day after induction of AIA, in contrast to IL-23R(GFP)+ γδ
T cells.
Also, the potential difference in production of IL-17 between
CD4+ and γδ T cells, which may have been induced by CD3 acti-
vation, could play a role in our transfer experiments, although a
previous study demonstrated that lack of IL-17A had no effect on
the severity of AIA [16]. Further research is needed to unravel the
C© 2019 The Authors. European Journal of Immunology published by
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Figure 6. IL-23R(GFP)+CD4+ T cells and γδ T cells are present in the
joints of arthritic IL-23R−/− mice. AIA was induced in WT, IL-23RGFP/+,
and IL-23R−/− mice and the joints were harvested at day 4 of AIA. Total
IL-23R+ T cell count was determined using GFP expression by flow
cytometry. WTmice were used as negative control for GFP. (A) Total IL-
23R(GFP)+ γδ T cell and (B) CD4+ T cell numbers. Data are representative
of three independent experiments and depicted asmeanwith SEM for n
= 4mice per group per experiment and compared usingMann–Whitney
test. p-values < 0.05 were considered statistically significant.
dependency of the IL-23R signaling in CCR6+CD4+ T cells versus
γδ T cells using IL-23R cell type specific knockout mice.
In conclusion, our study demonstrates that IL-23R+
CD4+CCR6+ T cells are present in the inflamed joints during the
early stages of arthritis. Furthermore, CD4+CCR6+ T cells, but
not γδ T cells, are important for IL-23R-dependent progression of
arthritis. In addition, our study demonstrates a new role for IL-23R
signaling in the regulation of CCR7 expression in the secondary
lymphoid tissues.
Material and methods
Mice
Eight to twelve weeks old male and female mice were used
for the experiments. Knock-in IL-23R-GFP reporter (IL-23RGFP/+)
mice were kindly provided by Dr. Mohamed Oukka and Dr.
Vijay K. Kuchroo [11]. As described previously by Awasthi et al.,
Figure 7. CD4+CCR6+ T cells, but not γδ T cells, are important for the
progressive phase of AIA. WT mice were immunized with methylated
BSA (mBSA)/CFA. Seven days later, sorted CD4+CCR6+ T cells or γδ
T cells from the spleens and LNs of these mice were transferred into
IL-23R−/− recipients. After 1.5 h, WT and recipient IL-23R−/− mice were
immunized with mBSA/CFA. AIA was induced with an intra-articular
injection of mBSA seven days later. Mice were sacrificed at day 4 of
AIA. Macroscopic scores of both inflamed joints representative of two
independent experiments are depicted as mean with SEM for n = 3–5
mice per group for each experiment. ***p < 0.001 (Mann–Whitney test)
compared to both WT and recipients of CD4+CCR6+ T cells.
IL-23RGFP/+ mice were generated by introduction of an IRES-GFP
cassette after exon 8 in the endogenous IL-23R gene [11]. The tar-
geting construct was electroporated into Bruce4 ES cells. Targeted
ES cells were injected into BALB/c blastocysts and male chimeras
were bred with female C57BL/6 mice. IL-23RGFP/+ mice were bred
as homozygotes in our own facility to obtain IL-23RGFP/GFP (also
referred to as IL-23R deficient or IL-23R−/− in this paper) and
IL-23R+/+ (WT) mice. Food and water were provided ad libitum,
and mice were kept under specific pathogen-free conditions. All
experiments were approved by the Erasmus MC Dutch Animal
Ethics Committee (DEC).
AIA induction
AIA was induced as previously described [37]. Briefly, CFA
(H37Ra; BD Difco) was supplemented with heat-killed mycobac-
terium tuberculosis (BD Difco) to obtain a final concentration of
5 mg/mL. The supplemented CFA was emulsified with an equal
volume of methylated BSA (mBSA). The final concentration of
mBSA in the emulsion was 4 mg/mL. Mice were immunized by
an intra-dermal injection of 100 µL of mBSA/CFA emulsion at
the tail base. Seven days later, mice received an intra-articular
injection of 6 µL mBSA (60 µg) in saline in both knee joints to
induce arthritis. The severity of arthritis in the knee joints was
scored macroscopically. After removing the skin from each knee,
the joint was scored on a scale from 0–2, where 0 = no inflamma-
tion, 1 = mild inflammation, 1.5 = marked inflammation, and 2
= severe inflammation, in increments of 0.25. A score of 0.25 was
given when the first signs of swelling and redness were present.
Themacroscopic scoring of the joint was performed by two blinded
observers.
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Histology
Knees were fixed in 10% formalin for 3 days, decalcified in 10%
EDTA (pH 7.2) for fourteen days, and subsequently infiltrated
and embedded in paraffin [37]. Coronal sections of 6 µm thick
slices were cut. Paraffin was removed by bringing sections through
xylene and gradients of ethanol (100–70%, 5 min per step) and
sections were then rinsed in distilled water for 5 min. For assess-
ment of inflammation, sections were stained with hematoxylin
for 5 min, washed with tap water for 5–10 min, and stained
with eosin for 45 s. Sections were dehydrated in gradients of
70–100% ethanol and xylene (1 min each) and mounted with
Entallan (Depex). Images were acquired using NanoZoomer
(Hamamatsu Photonics). Histopathological changes in the knee
joints were scored in the patella/femur/tibia region on three semi
serial sections of the joint, spaced 70 µm apart. Scoring was per-
formed by two blinded observers. Histopathological changes were
scored using the following parameters. Infiltration of cells was
scored on a scale of 0–3, depending on the amount of inflam-
matory cells in the synovial cavity (exudate) and synovial tissue
(infiltrate). A characteristic parameter in AIA is the loss of bone.
This destruction was graded on a scale of 0–3, ranging from no
damage to complete loss of the bone structure at four different
locations in the patella/femur region resulting in a cumulative
score of a maximum of 12.
Single cell isolation and flow cytometry
Patellae with adjacent synovium was cut into small pieces and
incubated for 1–1.5 h at 37°C with 5 µg/mL LiberaseTM (collage-
nase I and II, Sigma-Aldrich) in Roswell Park Memorial Institute
1640 medium. Single cell suspension of spleens and synovium
was prepared using 100 µm cell strainers (Falcon). Erythrocytes
in splenic cell suspension were lysed using Gey’s solution. Single
cell suspension from the LNs was prepared using tubes with 35
µm nylon mesh cell strainer snap cap (Falcon).
Single cell suspensions were incubated in Fc block (anti-FcγR
II and III; clone 2.4G2) for 20 min at 4°C and were subsequently
incubated with anti-mouse CD3, TCR-γδ, CD45, CCR6 (all from
BioLegend), CD4, CD8, and CD62L (all from BD Pharmingen)
antibodies for 30 min at 4°C in the dark. For exclusion of dead
cells, samples were incubated with Fixable Viability Dye eFluor506
(eBioscience) for 30 min at 4°C in the dark and fixed with
2% paraformaldehyde for 5 min. For intracellular flow cytom-
etry, cells were stimulated using 50 ng/mL PMA, 500 ng/mL
ionomycin (Sigma-Aldrich) and Golgistop (BD Bioscience) as
described by the manufacturer for 4 h. Cells were stained with
cell surface markers as described above. Fixable Viability Dye
eFluor506 (eBioscience) was used to exclude dead cells. After
fixation with 2% paraformaldehyde, cells were permeabilized
using 0.5% saponin buffer and stained with antibodies against
IL-17A (BD Pharmingen). Cells were acquired on LSRII flow
cytometer (BD Biosciences) and analyzed using FlowJo v7.6 soft-
ware (Tree Star). We have adhered to the guidelines of ‘Guidelines
for the use of flow cytometry and cell sorting in immunological
studies’ [38].
Cell sorting and adoptive transfer
WT mice were immunized with mBSA/CFA as described above.
Seven days later, single cell suspensions from the spleens and LNs
were prepared as described above. For sorting T cells, CD3+ cells
were pre-purified with MACS (Miltenyi Biotec) according to man-
ufacturer’s instructions. The positively selected cells were used
for the FACS. Dead cells were excluded with 4’,6-diamidino-2-
fenylindool. CD3+CD8−TCRγδ−CD4+CD62L−CCR6+ (referred to
as CD4+CCR6+ T) cells or CD3+TCRγδ+ (γδ T) cells were sorted.
Sorted cells were resuspended in 0.9% NaCl. Per mouse, 1.2×105
CD4+CCR6+ T cells or 6×104 γδ T cells were injected in the tail
vein of age and sex matched recipient mice in a volume of 100
µL. After 1.5 h, recipient mice were immunized with mBSA/CFA,
and seven days later, arthritis was induced via an intra-articular
injection of mBSA.
Cell culture and RT-PCR
Splenic cell suspensions were prepared as described above.
1×105 cells were cultured in Iscove’s modified Dulbecco’s
medium supplemented with 10% fetal calf serum (Gibco),
2 mM L-glutamine, 100 U/mL penicillin/streptomycin (Lonza)
and 50 µM β-mercaptoethanol (Sigma-Aldrich) for 3 days. Cells
were cultured in U-bottom 96-well plates and left untreated
or treated with 50 ng/mL recombinant IL-23 (R&D Systems).
RNA was isolated using the GenElute Mammalian Total RNA
Miniprep Kit according to manufacturer’s instructions (Sigma
Aldrich). RNA was treated with 0.1 U/µL DNAse I Amplifi-
cation Grade (Invitrogen). cDNA was synthesized using ran-
dom hexamer primers and 10 U/µL Superscript II (Invit-
rogen). Primers were designed with ProbeFinder software
(Roche Applied Sciences, USA) and probes were used from
the Universal Probe Library (Roche Applied Science, USA).
18srRNA (forward primer 5′-GCAATTATTCCCCATGAACG-3′;
reverse primer 5′- GGGACTTAATCAACGCAAGC-3′; probe 48)
was used to normalize gene expression. For CCR7, forward
primer 5′- CAGGGAAACCCAGGAAAAAC-3′ and reverse primer 5′-
ATCTTGGCAGAAGCACACCT-3′ with probe 77 were used. Real-
time PCR was performed using the Viia7 system and data were
analyzed using QuantStudio Real-time PCR software version 1.3
(Applied Biosystems, USA).
Statistical analysis
Data are expressed as mean ± SEM. Differences between two
groups were tested using Mann–Whitney test and differences
between multiple groups were tested using Kruskall–Wallis test
C© 2019 The Authors. European Journal of Immunology published by
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followed by Dunn’s multiple comparison (GraphPad Prism 5).
p-values < 0.05 were considered statistically significant.
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